Anthony Crimaldi, MD
Radiation Oncology · Culpeper, VANPI 1700845625
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,000 of the $9,880 with a category attached, or 70.9%. Sirtex Medical Inc accounts for 97.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $5,463 and has fallen 98.6% since, to $77 in 2024. Among radiation oncology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $340.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sirtex Medical Inc$10K
- Medtronic$161
- Johnson & Johnson$99
What the payments were for
- Speaking & faculty fees$7,00071%
- Travel & lodging$1,51415%
- Food & beverage$1,36614%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sirtex Medical Inc | 27 | $9,620 |
| Medtronic | 1 | $161 |
| Johnson & Johnson | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,880 in reported general payments places this provider in the 90th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 13 | $2,485 |
| Sucralfate | 12 | $2,265 |
| Tamsulosin Hcl | 158 | $2,202 |
| Pilocarpine Hcl | 23 | $1,520 |
| Lidocaine Hcl ViscousLidocaine Hcl | 38 | $1,392 |
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $383 |
| SsdSilver Sulfadiazine | 11 | $360 |
| Oxycodone Hcl | 27 | $323 |
| Dexamethasone | 14 | $221 |
| Levothyroxine Sodium | 20 | $164 |
| Gabapentin | 14 | $138 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $128 |
| Montelukast Sodium | 16 | $124 |
| Bicalutamide | 13 | $107 |
| Ondansetron Hcl | 11 | $92 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Culpeper
- Shiv KhandelwalCulpeper$511
- Daniel KimFairfax$406K
- Samir KananiFairfax$90K
- David PenberthyCharlottesville$67K
- Gopal BajajFairfax$23K
- Ashish ChawlaFairfax$14K
- David BuckRoanoke$13K
- Kara RomanoCharlottesville$11K
- Gregory SibleyFairfax$10K
- Kevin ChoeFairfax$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.